Spectrum of BCR-ABL mutations in Azerbaijanian imatinib-resistant patients with chronic myeloid leukemia

Conclusion: T315I was the most commonly identified BCR-ABL1 mutation in TKI-resistant CML patients of Azerbaijani origin, being associated with disease progression and poor OS.PMID:38188610 | PMC:PMC10766836 | DOI:10.3389/pore.2023.1611518

Source: Pathology Oncology Research - January 8, 2024 Category: Pathology Authors: Aypara Hasanova Chingiz Asadov Nigar Karimova Aytan Shirinova Gunay Aliyeva Zohra Alimirzoyeva Source Type: research